- Home
- ADC vs CAI Comparison
ADC vs CAI Comparison
Compare ADC & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADC | CAI |
|---|---|---|
| Founded | 1971 | 2008 |
| Country | United States | United States |
| Employees | 90 | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 6.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ADC | CAI |
|---|---|---|
| Price | $80.00 | $18.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $83.35 | $32.78 |
| AVG Volume (30 Days) | 1.0M | ★ 2.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.94% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.94 | $24.26 |
| Revenue Next Year | $8.44 | $22.60 |
| P/E Ratio | $43.33 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $68.98 | $17.15 |
| 52 Week High | $82.08 | $42.50 |
Technical Indicators
Market Signals| Indicator | ADC | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 58.13 | 41.05 |
| Support Level | $70.94 | $17.15 |
| Resistance Level | $82.08 | $21.47 |
| Average True Range (ATR) | 1.26 | 1.07 |
| MACD | -0.38 | 0.16 |
| Stochastic Oscillator | 31.64 | 26.57 |
Price Performance
Historical ComparisonAbout ADC Agree Realty Corporation
Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.